Katie Woodley cannot answer specific questions about your pets medical issues or make medical recommendations for your pet without first establishing a veterinarian-client-patient relationship
Clinical studies explored DSIP in conditions characterized by stress dysregulation, including chronic stress syndromes, burnout, and disorders with stress-related components like hypertension
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Biliary-Related Diseases
Signs you're ready to move to the next dose: GI symptoms (nausea, vomiting, diarrhea) have resolved or are minimal for at least 7 consecutive days Appetite suppression remains noticeable but you sense a plateau effect developing at the current dose You have completed at least 4 full weeks at the current dose level You have no significant intercurrent illness that might confuse attribution of new symptoms Signs to wait: Ongoing nausea or vomiting, even if mild, at the end of the current dose phase A recent GI illness (unrelated to the medication) that makes it hard to attribute current symptoms A major life stressor or schedule disruption that might amplify side effects Fewer than 4 weeks at the current dose, regardless of how you feel When in doubt, an additional week at the current dose costs very little
Acknowledgements The authors thank all participants and colleagues who contributed to this study but did not meet authorship criteria
